Si-Bone
Develops an implant to tackle lower back pains.
Launch date
Employees
Market cap
€581m
Enterprise valuation
€479m (Public information from Sep 2024)
Share price
$15.83 SIBN
San Jose California (HQ)
Financials
Estimates*
| USD | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Revenues | 67.3m | 73.4m | 90.2m | 106m | 139m | 166m | 195m |
| % growth | 22 % | 9 % | 23 % | 18 % | 31 % | 19 % | 17 % |
| EBITDA | (33.5m) | (37.6m) | (51.2m) | (58.4m) | (34.4m) | - | - |
| % EBITDA margin | (50 %) | (51 %) | (57 %) | (55 %) | (25 %) | - | - |
| Profit | (38.4m) | (43.7m) | (56.6m) | (61.3m) | (43.3m) | - | - |
| % profit margin | (57 %) | (60 %) | (63 %) | (58 %) | (31 %) | - | - |
| R&D budget | 7.3m | 9.5m | 12.4m | 13.6m | 15.0m | - | - |
| R&D % of revenue | 11 % | 13 % | 14 % | 13 % | 11 % | - | - |
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | N/A | - | |
| N/A | $1.5m | Series A | |
$10.6m | Series B | ||
$16.0m | Late VC | ||
$33.0m | Late VC | ||
$21.0m | Late VC | ||
$26.0m | Late VC | ||
| N/A | $108m | IPO | |
$40.0m | Debt | ||
* | N/A | $77.0m | Post IPO Equity |
| Total Funding | €98.3m | ||
Recent News about Si-Bone
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.